Literature DB >> 7104417

Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia.

L E Adler, E Pachtman, R D Franks, M Pecevich, M C Waldo, R Freedman.   

Abstract

The action of CNS inhibitory neuronal mechanisms was tested in acutely psychotic unmedicated schizophrenic patients and in normal controls. An early positive component of the auditory average evoked response recorded at the vertex 50 msec after a click stimulus was studied. Stimuli were delivered at 10-sec intervals to establish a base-line response. Inhibitory mechanisms were then tested using a conditioning-testing paradigm by assessing the change in response to a second stimulus following the first at either 0.5, 1.0, or 2.0-sec intervals. At the 0.5-sec interval, normal controls had over a 90% mean decrement in response, whereas schizophrenics showed less than a 15% mean decrement. At 2-sec intervals, responses from normals were still 30 to 50% diminished, but those from schizophrenics showed an increased response to the stimulus compared to base line. The data suggest that normally present inhibitory mechanisms are markedly reduced in schizophrenics. Failure of these inhibitory mechanisms may be responsible for the defects in sensory gating which are thought to be an important part of the pathophysiology of schizophrenia.

Entities:  

Mesh:

Year:  1982        PMID: 7104417

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  195 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

3.  Hippocampal pyramidal cell disarray correlates negatively to cell number: implications for the pathogenesis of schizophrenia.

Authors:  S A Jönsson; A Luts; N Guldberg-Kjaer; A Brun
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

4.  Relevance of attention in auditory sensory gating paradigms in schizophrenia A pilot study.

Authors:  Klevest Gjini; Scott Burroughs; Nash N Boutros
Journal:  J Psychophysiol       Date:  2011       Impact factor: 1.333

5.  Relationships between sensory "gating out" and sensory "gating in" of auditory evoked potentials in schizophrenia: a pilot study.

Authors:  Klevest Gjini; Cynthia Arfken; Nash N Boutros
Journal:  Schizophr Res       Date:  2010-05-26       Impact factor: 4.939

6.  Mapping repetition suppression of the N100 evoked response to the human cerebral cortex.

Authors:  Nash N Boutros; Klevest Gjini; Horst Urbach; Mark E Pflieger
Journal:  Biol Psychiatry       Date:  2011-01-28       Impact factor: 13.382

7.  Event-related potential studies of post-traumatic stress disorder: a critical review and synthesis.

Authors:  Arash Javanbakht; Israel Liberzon; Alireza Amirsadri; Klevest Gjini; Nash N Boutros
Journal:  Biol Mood Anxiety Disord       Date:  2011-10-12

8.  Distinct neural generators of sensory gating in schizophrenia.

Authors:  Terrance J Williams; Keith H Nuechterlein; Kenneth L Subotnik; Cindy M Yee
Journal:  Psychophysiology       Date:  2010-08-23       Impact factor: 4.016

9.  A reduced somatosensory gating response in individuals with multiple sclerosis is related to walking impairment.

Authors:  David J Arpin; James E Gehringer; Tony W Wilson; Max J Kurz
Journal:  J Neurophysiol       Date:  2017-07-19       Impact factor: 2.714

10.  P50 inhibitory sensory gating in schizophrenia: analysis of recent studies.

Authors:  Robert Freedman; Amanda M Olsen-Dufour; Ann Olincy
Journal:  Schizophr Res       Date:  2020-02-13       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.